Affiliation:
1. School of BioSciences and Technology, Vellore Institute of Technology, Vellore, India
Abstract
Abstract:
Osteoporosis, one of the most prevalent bone illnesses, majorly affects postmenopausal
women and men over 50 years of age. Osteoporosis is associated with an increased
susceptibility to fragility fractures and can result in persistent pain and significant impairment in
affected individuals. The primary method for diagnosing osteoporosis involves the assessment of
bone mineral density (BMD) through the utilisation of dual energy x-ray absorptiometry
(DEXA). The integration of a fracture risk assessment algorithm with bone mineral density
(BMD) has led to significant progress in the diagnosis of osteoporosis. Given that osteoporosis is
a chronic condition and multiple factors play an important role in maintaining bone mass,
comprehending its underlying mechanism is crucial for developing more effective pharmaceutical
interventions for the disease. The effective management of osteoporosis involves the
utilisation of appropriate pharmacological agents in conjunction with suitable dietary
interventions and lifestyle modifications. This review provides a comprehensive understanding
of the types of osteoporosis and elucidates the currently available pharmacological treatment
options and their related mechanism of action and usage.
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmaceutical Science,Biotechnology
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献